Revolution Medicines (RVMD) — insider trading
Health Care · NASDAQ
Revolution Medicines (RVMD) has 167 reported SEC Form 4 insider transactions in our data, including 81 open-market sales among the most recent 100 (latest 2026-09-29).
Recent Form 4 transactions
Showing the 100 most recent of 167 recorded transactions. See all on SEC EDGAR →
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-29 | Sandler Alan B. | Officer (Chief Development Officer) | Option exercise / conversion (derivative) | 6,000 | — | $0 | Form 4 |
| 2026-09-29 | Sandler Alan B. | Officer (Chief Development Officer) | Open-market sale | 301 | $204.72 | $61.6K | Form 4 |
| 2026-09-29 | Sandler Alan B. | Officer (Chief Development Officer) | Open-market sale | 1,199 | $203.91 | $244.5K | Form 4 |
| 2026-09-29 | Sandler Alan B. | Officer (Chief Development Officer) | Open-market sale | 1,000 | $202.81 | $202.8K | Form 4 |
| 2026-09-29 | Sandler Alan B. | Officer (Chief Development Officer) | Open-market sale | 1,609 | $201.72 | $324.6K | Form 4 |
| 2026-09-29 | Sandler Alan B. | Officer (Chief Development Officer) | Open-market sale | 2,200 | $200.82 | $441.8K | Form 4 |
| 2026-09-29 | Sandler Alan B. | Officer (Chief Development Officer) | Option exercise / conversion | 6,000 | $58.84 | $353.0K | Form 4 |
| 2026-09-25 | Cislini Jeff | Officer (SVP & General Counsel) | Open-market sale | 765 | $207.32 | $158.6K | Form 4 |
| 2026-09-25 | Mancini Anthony | Officer (See Remarks) | Option exercise / conversion (derivative) | 3,121 | — | $0 | Form 4 |
| 2026-09-25 | Mancini Anthony | Officer (See Remarks) | Open-market sale | 3,121 | $200.54 | $625.9K | Form 4 |
| 2026-09-25 | Mancini Anthony | Officer (See Remarks) | Option exercise / conversion | 3,121 | $33.62 | $104.9K | Form 4 |
| 2026-09-24 | Mancini Anthony | Officer (See Remarks) | Open-market sale | 587 | $200.00 | $117.4K | Form 4 |
| 2026-09-22 | ANDERSON ELIZABETH M | Director | Option exercise / conversion (derivative) | 5,070 | — | $0 | Form 4 |
| 2026-09-22 | ANDERSON ELIZABETH M | Director | Open-market sale | 100 | $195.15 | $19.5K | Form 4 |
| 2026-09-22 | ANDERSON ELIZABETH M | Director | Open-market sale | 1,500 | $194.59 | $291.9K | Form 4 |
| 2026-09-22 | ANDERSON ELIZABETH M | Director | Open-market sale | 2,648 | $193.44 | $512.2K | Form 4 |
| 2026-09-22 | ANDERSON ELIZABETH M | Director | Open-market sale | 4,985 | $192.54 | $959.8K | Form 4 |
| 2026-09-22 | ANDERSON ELIZABETH M | Director | Open-market sale | 910 | $191.85 | $174.6K | Form 4 |
| 2026-09-22 | ANDERSON ELIZABETH M | Director | Option exercise / conversion | 5,070 | $1.12 | $5.7K | Form 4 |
| 2026-09-18 | Mancini Anthony | Officer (See Remarks) | Open-market sale | 1,764 | $196.94 | $347.4K | Form 4 |
| 2026-09-16 | Sandler Alan B. | Officer (Chief Development Officer) | Open-market sale | 336 | $199.30 | $67.0K | Form 4 |
| 2026-09-16 | Sandler Alan B. | Officer (Chief Development Officer) | Open-market sale | 5 | $194.96 | $975 | Form 4 |
| 2026-09-16 | Mancini Anthony | Officer (See Remarks) | Open-market sale | 1,747 | $199.30 | $348.2K | Form 4 |
| 2026-09-16 | Mancini Anthony | Officer (See Remarks) | Open-market sale | 27 | $195.05 | $5.3K | Form 4 |
| 2026-09-16 | Kelsey Stephen Michael | Officer (See Remarks) | Open-market sale | 5,484 | $199.30 | $1.09M | Form 4 |
| 2026-09-16 | Kelsey Stephen Michael | Officer (See Remarks) | Open-market sale | 85 | $195.01 | $16.6K | Form 4 |
| 2026-09-16 | Horn Margaret A | Officer (Chief Operating Officer) | Open-market sale | 4,891 | $199.30 | $974.8K | Form 4 |
| 2026-09-16 | Horn Margaret A | Officer (Chief Operating Officer) | Open-market sale | 76 | $195.01 | $14.8K | Form 4 |
| 2026-09-16 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 13,775 | $199.30 | $2.75M | Form 4 |
| 2026-09-16 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 213 | $195.01 | $41.5K | Form 4 |
| 2026-09-16 | Cislini Jeff | Officer (SVP & General Counsel) | Open-market sale | 3,314 | $199.30 | $660.5K | Form 4 |
| 2026-09-16 | Cislini Jeff | Officer (SVP & General Counsel) | Open-market sale | 52 | $195.01 | $10.1K | Form 4 |
| 2026-09-16 | Anders Jack | Officer (Chief Financial Officer) | Open-market sale | 3,992 | $199.30 | $795.6K | Form 4 |
| 2026-09-16 | Anders Jack | Officer (Chief Financial Officer) | Open-market sale | 61 | $195.00 | $11.9K | Form 4 |
| 2026-09-11 | Kelsey Stephen Michael | Officer (See Remarks) | Option exercise / conversion (derivative) | 40,031 | $40.74 | $1.63M | Form 4 |
| 2026-09-11 | Kelsey Stephen Michael | Officer (See Remarks) | Option exercise / conversion (derivative) | 52,500 | $42.45 | $2.23M | Form 4 |
| 2026-09-11 | Kelsey Stephen Michael | Officer (See Remarks) | Open-market sale | 3,270 | $205.81 | $673.0K | Form 4 |
| 2026-09-11 | Kelsey Stephen Michael | Officer (See Remarks) | Open-market sale | 4,995 | $204.84 | $1.02M | Form 4 |
| 2026-09-11 | Kelsey Stephen Michael | Officer (See Remarks) | Open-market sale | 17,949 | $203.87 | $3.66M | Form 4 |
| 2026-09-11 | Kelsey Stephen Michael | Officer (See Remarks) | Open-market sale | 18,869 | $203.06 | $3.83M | Form 4 |
| 2026-09-11 | Kelsey Stephen Michael | Officer (See Remarks) | Open-market sale | 21,447 | $201.75 | $4.33M | Form 4 |
| 2026-09-11 | Kelsey Stephen Michael | Officer (See Remarks) | Open-market sale | 13,368 | $200.78 | $2.68M | Form 4 |
| 2026-09-11 | Kelsey Stephen Michael | Officer (See Remarks) | Open-market sale | 11,833 | $200.11 | $2.37M | Form 4 |
| 2026-09-11 | Kelsey Stephen Michael | Officer (See Remarks) | Open-market sale | 800 | $198.55 | $158.8K | Form 4 |
| 2026-09-11 | Kelsey Stephen Michael | Officer (See Remarks) | Option exercise / conversion | 40,031 | $40.74 | $1.63M | Form 4 |
| 2026-09-11 | Kelsey Stephen Michael | Officer (See Remarks) | Option exercise / conversion | 52,500 | $42.45 | $2.23M | Form 4 |
| 2026-09-10 | Mancini Anthony | Officer (See Remarks) | Option exercise / conversion (derivative) | 9,363 | — | $0 | Form 4 |
| 2026-09-10 | Mancini Anthony | Officer (See Remarks) | Open-market sale | 300 | $207.17 | $62.2K | Form 4 |
| 2026-09-10 | Mancini Anthony | Officer (See Remarks) | Open-market sale | 1,179 | $206.10 | $243.0K | Form 4 |
| 2026-09-10 | Mancini Anthony | Officer (See Remarks) | Open-market sale | 2,420 | $205.05 | $496.2K | Form 4 |
| 2026-09-10 | Mancini Anthony | Officer (See Remarks) | Open-market sale | 5,530 | $204.14 | $1.13M | Form 4 |
| 2026-09-10 | Mancini Anthony | Officer (See Remarks) | Open-market sale | 6,019 | $203.28 | $1.22M | Form 4 |
| 2026-09-10 | Mancini Anthony | Officer (See Remarks) | Option exercise / conversion | 9,363 | $33.62 | $314.8K | Form 4 |
| 2026-09-08 | Kim Lorence H. | Director | Open-market sale | 371 | $212.27 | $78.8K | Form 4 |
| 2026-09-08 | Kim Lorence H. | Director | Open-market sale | 3,844 | $211.36 | $812.5K | Form 4 |
| 2026-09-08 | Kim Lorence H. | Director | Open-market sale | 4,730 | $210.50 | $995.7K | Form 4 |
| 2026-09-08 | Kim Lorence H. | Director | Open-market sale | 2,853 | $209.56 | $597.9K | Form 4 |
| 2026-09-08 | Kim Lorence H. | Director | Open-market sale | 3,587 | $208.55 | $748.1K | Form 4 |
| 2026-09-08 | Kim Lorence H. | Director | Open-market sale | 999 | $207.33 | $207.1K | Form 4 |
| 2026-09-08 | Kim Lorence H. | Director | Open-market sale | 706 | $206.60 | $145.9K | Form 4 |
| 2026-08-31 | Kim Lorence H. | Director | Open-market sale | 625 | $206.15 | $128.8K | Form 4 |
| 2026-08-31 | Kim Lorence H. | Director | Open-market sale | 2,128 | $205.19 | $436.6K | Form 4 |
| 2026-08-31 | Kim Lorence H. | Director | Open-market sale | 7,271 | $204.35 | $1.49M | Form 4 |
| 2026-08-31 | Kim Lorence H. | Director | Open-market sale | 26,160 | $203.55 | $5.32M | Form 4 |
| 2026-08-31 | Kim Lorence H. | Director | Open-market sale | 12,919 | $202.48 | $2.62M | Form 4 |
| 2026-08-31 | Kim Lorence H. | Director | Open-market sale | 6,597 | $201.47 | $1.33M | Form 4 |
| 2026-08-31 | Kim Lorence H. | Director | Open-market sale | 300 | $200.56 | $60.2K | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Option exercise / conversion (derivative) | 80,000 | — | $0 | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 126 | $212.06 | $26.7K | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 229 | $211.46 | $48.4K | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 126 | $210.40 | $26.5K | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 1,405 | $209.27 | $294.0K | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 937 | $208.36 | $195.2K | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 177 | $207.25 | $36.7K | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 127 | $212.06 | $26.9K | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 245 | $211.47 | $51.8K | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 136 | $210.40 | $28.6K | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 1,351 | $209.28 | $282.7K | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 951 | $208.36 | $198.2K | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 190 | $207.25 | $39.4K | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 3,621 | $212.08 | $767.9K | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 6,583 | $211.33 | $1.39M | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 3,813 | $210.25 | $801.7K | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 35,938 | $209.26 | $7.52M | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 24,917 | $208.37 | $5.19M | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Open-market sale | 5,128 | $207.23 | $1.06M | Form 4 |
| 2026-08-21 | GOLDSMITH MARK A | Director, Officer (See Remarks) | Option exercise / conversion | 80,000 | $4.73 | $378.4K | Form 4 |
| 2026-08-21 | Cislini Jeff | Officer (General Counsel) | Option exercise / conversion (derivative) | 26,600 | — | $0 | Form 4 |
| 2026-08-21 | Cislini Jeff | Officer (General Counsel) | Option exercise / conversion (derivative) | 29,680 | — | $0 | Form 4 |
| 2026-08-21 | Cislini Jeff | Officer (General Counsel) | Open-market sale | 3,314 | $212.06 | $702.8K | Form 4 |
| 2026-08-21 | Cislini Jeff | Officer (General Counsel) | Open-market sale | 4,500 | $211.34 | $951.0K | Form 4 |
| 2026-08-21 | Cislini Jeff | Officer (General Counsel) | Open-market sale | 2,540 | $210.26 | $534.1K | Form 4 |
| 2026-08-21 | Cislini Jeff | Officer (General Counsel) | Open-market sale | 25,817 | $209.25 | $5.40M | Form 4 |
| 2026-08-21 | Cislini Jeff | Officer (General Counsel) | Open-market sale | 17,323 | $208.37 | $3.61M | Form 4 |
| 2026-08-21 | Cislini Jeff | Officer (General Counsel) | Open-market sale | 3,400 | $207.24 | $704.6K | Form 4 |
| 2026-08-21 | Cislini Jeff | Officer (General Counsel) | Option exercise / conversion | 26,600 | $21.61 | $574.8K | Form 4 |
| 2026-08-21 | Cislini Jeff | Officer (General Counsel) | Option exercise / conversion | 29,680 | $18.56 | $550.9K | Form 4 |
| 2026-06-29 | Patel Sushil | Director | Option exercise / conversion (derivative) | 2,955 | — | $0 | Form 4 |
| 2026-06-29 | Patel Sushil | Director | Open-market sale | 881 | $192.61 | $169.7K | Form 4 |
| 2026-06-29 | Patel Sushil | Director | Open-market sale | 541 | $191.87 | $103.8K | Form 4 |
Ask the chat about RVMD's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Revolution Medicines (RVMD).
Last updated 2026-09-29 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.